Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet

Canada Type II Ongoing · initiated 2026-10-21

Packaging. Verify whether your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any healt…

Dantrium Intravenous (Dantrolene sodium for injection)

Canada Type I Ongoing · initiated 2026-10-19

Contamination. Consult your healthcare provider for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health …

Aleve

Canada Type III Ongoing · initiated 2026-10-15

Other. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.Contac…

Claritin Allergy Tablets

Canada Type III Ongoing · initiated 2026-10-15

Other. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.Contac…

Flintstones Complete Multivitamins and Minerals

Canada Type III Ongoing · initiated 2026-10-15

Other. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.Contac…

PMS-FAMPRIDINE

Canada Type II Ongoing · initiated 2026-10-06

Contamination. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concern…

PMS-Carvedilol

Canada Type II Ongoing · initiated 2026-10-06

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Carvedilol

Canada Type II Ongoing · initiated 2026-10-06

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

PDP-DIPHENHYDRAMINE

Canada Type II Ongoing · initiated 2026-10-05

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

CARVEDILOL

Canada Type II Ongoing · initiated 2026-10-05

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Preferred Pharmaceuticals, Inc.

US Class II Ongoing · initiated 2026-09-28

Failed Content Uniformity Specifications

SARCLISA

Canada Type I Ongoing · initiated 2026-09-25

Product quality. Only a limited number of units within the lot are affected by this recall. Do not assume your product is affected solely because the lot number…

SUN PHARMACEUTICAL INDUSTRIES INC

US Class III Ongoing · initiated 2026-09-25

Failed Impurities/Degradation Specifications

SUN PHARMACEUTICAL INDUSTRIES INC

US Class III Ongoing · initiated 2026-09-25

Failed Impurities/Degradation Specifications

SUN PHARMACEUTICAL INDUSTRIES INC

US Class III Ongoing · initiated 2026-09-25

Failed Impurities/Degradation Specifications

Apo-Semaglutide Injection

Canada Type II Ongoing · initiated 2026-09-24

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Apothecary Pharma LLC

US Class II Ongoing · initiated 2026-09-24

Lack of Assurance of Sterility

Apothecary Pharma LLC

US Class II Ongoing · initiated 2026-09-24

Lack of Assurance of Sterility

Apotex Corp.

US Class II Ongoing · initiated 2026-09-23

Failed dissolution specifications.

J&J INNOVATIVE MEDICINE

US Class II Ongoing · initiated 2026-09-23

Presence of particulate matter.

IMAAVY Solution

Canada Type II Ongoing · initiated 2026-09-21

Product quality. Verify if your product is affected.Consult your healthcare provider for any health concerns.Contact the recalling firm if you have any question…

Aurobindo Pharma USA Inc

US Not Yet Classified Ongoing · initiated 2026-09-18

Discoloration: consumer complaints received for discolored tablets

Cipla USA, Inc.

US Class II Ongoing · initiated 2026-09-18

Failed Impurities/Degradation Specifications

Aurolab Trust

US Class II Ongoing · initiated 2026-09-17

Lack of Assurance of Sterility

Ajanta Pharma USA Inc

US Class II Ongoing · initiated 2026-09-17

Failed Dissolution Specifications: below specification